Central Garden & Pet closed its acquisition of Champion USA’s U.S. assets on December 12, 2025, adding the EPA‑approved JustiFLY® fly‑control product line to its portfolio and expanding its presence in the growing sustainable livestock fly‑control market.
The deal is part of Central’s long‑standing strategy of growth through acquisitions; the company has completed more than 60 M&A transactions since 1992. By integrating Champion’s employees into its Professional business unit, Central will preserve the brand’s strong customer relationships while leveraging its nationwide distribution network to accelerate market penetration.
Central’s Q1 2025 results—net sales of $3.1 billion and earnings per share of $0.21 versus $0.01 a year earlier—demonstrate the company’s ability to generate high‑margin growth. Management maintained its fiscal‑2025 guidance, underscoring confidence in continued demand for its pet, garden, and animal‑health products.
Champion USA has operated for more than 15 years, serving over 300,000 cattle producers and treating more than 50 million head of cattle. Its JustiFLY® line is residue‑free, EPA‑approved, and designed to avoid harm to beneficial insects such as dung beetles, positioning it well in a market that increasingly values sustainability.
The sustainable livestock fly‑control market is expanding as producers seek residue‑free, environmentally responsible solutions. Champion’s proven technology and established customer base provide Central with immediate access to a high‑margin, recurring‑sales category that complements its existing animal‑health offerings.
CEO Niko Lahanas said the acquisition “strengthens our position in one of the fastest growing segments in animal health and enhances our ability to deliver effective, high‑quality solutions for cattle producers nationwide.” Champion President André Rocha added that joining Central “will enable us to reach more ranchers with Central’s resources and distribution network.”
Shares of Central Garden & Pet rose 0.7 % in late morning trading on December 16, reflecting investor confidence in the strategic fit and the company’s strong financial performance.
The financial terms of the transaction were not disclosed, so the deal value remains unknown.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.